Advanced search
Publication Cover
Current Medical Research and Opinion Volume 29, 2013 - Issue 7
Submit an article Journal homepage
512
Views
13
CrossRef citations to date
0
Altmetric
Brief Report

Treatment adherence with vildagliptin compared to sulphonylurea as add-on to metformin in Muslim patients with type 2 diabetes mellitus fasting during Ramadan

W. HanifUniversity of Birmingham BirminghamUK
,
W. MalikHeart of England NHS Foundation Trust BirminghamUK
,
M. HassaneinBetsi Cadawalder University Health Board WalesUK
,
A. KamalHeart of England NHS Foundation Trust BirminghamUK
,
P. GeransarNovartis Pharmaceuticals UK Limited Frimley/CamberleyUK
,
C. AndrewsNovartis Pharmaceuticals UK Limited Frimley/CamberleyUK
,
M. AzamHeart of England NHS Foundation Trust BirminghamUK
&
A.H. BarnettUniversity of Birmingham BirminghamUK;Heart of England NHS Foundation Trust BirminghamUKCorrespondence[email protected]
 show all
Pages 807-811 | Accepted 03 May 2013, Published online: 31 May 2013

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kamran MA Aziz. (2015) Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients. Diabetes, Metabolic Syndrome and Obesity 8, pages 207-211.
Read now
Anja Schweizer, Serge Halimi & Sylvie Dejager. (2014) Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan. Vascular Health and Risk Management 10, pages 15-24.
Read now

Articles from other publishers (11)

Hoda Gad, Tabraiz Hayat, Hamad Al-Muhannadi, Balal Rasheed Malik, Paul Mussleman & Rayaz A. Malik. (2021) Efficacy and safety of the newer oral hypoglycemic agents in patients with T2DM during Ramadan: A systematic review and meta-analysis. Diabetes Research and Clinical Practice 172, pages 108562.
Crossref
W. Hanif, V. Patel, S.N. Ali, A. Karamat, M. Saeed, M. Hassanein, A. Syed, T.A. Chowdhury, A. Farooqi & K. Khunti. (2020) The South Asian Health Foundation (UK) guidelines for managing diabetes during Ramadan. Diabetes Research and Clinical Practice 164, pages 108145.
Crossref
Bárbara Badanta-Romero, Rocío de Diego-Cordero & Estefanía Rivilla-García. (2018) Influence of Religious and Spiritual Elements on Adherence to Pharmacological Treatment. Journal of Religion and Health 57:5, pages 1905-1917.
Crossref
Zachary T. Bloomgarden, Kaan Tunceli, Jinan Liu, Kimberly G. Brodovicz, Panagiotis Mavros, Samuel S. Engel, Larry Radican, Yong Chen, Swapnil Rajpathak, Ying Qiu, Philippe Brudi & Vivian Fonseca. (2017) Adherence, persistence, and treatment discontinuation with sitagliptin compared with sulfonylureas as add-ons to metformin: A retrospective cohort database study. Journal of Diabetes 9:7, pages 677-688.
Crossref
S. Ali, M. J. Davies, E. M. Brady, L. J. Gray, K. Khunti, S. A. Beshyah & W. Hanif. (2016) Guidelines for managing diabetes in Ramadan. Diabetic Medicine 33:10, pages 1315-1329.
Crossref
Mohamed Khattab, Khalifa Mahmoud & Inass Shaltout. (2016) Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study. Diabetes Therapy 7:3, pages 551-560.
Crossref
Huai Heng Loh, Anne Yee, Huai Seng Loh, Norlela Sukor & Nor Azmi Kamaruddin. (2016) Comparative studies of dipeptidyl peptidase 4 inhibitor vs sulphonylurea among Muslim Type 2 diabetes patients who fast in the month of Ramadan: A systematic review and meta-analysis. Primary Care Diabetes 10:3, pages 210-219.
Crossref
Ehab Mudher Mikhael. (2016) Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients. Journal of Diabetes Research 2016, pages 1-10.
Crossref
S. Halimi & M. Lévy. (2014) Prise en charge des patients diabétiques de type 2 durant le Ramadan : quelle place pour les inhibiteurs de la DPP-4 ?. Médecine des Maladies Métaboliques 8:3, pages 299-305.
Crossref
Gillian M. Keating. (2014) Vildagliptin: A Review of Its Use in Type 2 Diabetes Mellitus. Drugs 74:5, pages 587-610.
Crossref
Serge Halimi, Marc Levy, Dominique Huet, Stéphane Quéré & Sylvie Dejager. (2013) Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study. Diabetes Therapy 4:2, pages 385-398.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.